Keywords: ترومبوآمبولی وریدی; Haemorrhage; pain; patient safety; surgical complications; surgical site infection; venous thromboembolism;
مقالات ISI ترومبوآمبولی وریدی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Prophylactic anticoagulation; Primary bone sarcoma;
Keywords: ترومبوآمبولی وریدی; Argatroban; Heparin; Lumbar vertebrae; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Gender; Cancer; Anticoagulant drugs; Recurrence; Hemorrhage; Mortality;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Hormonal therapy; Women; Recurrences;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Treatment duration; Anticoagulation; Relapses; Hemorrhages; Tromboembolia venosa; Duración del tratamiento; Anticoagulación; Recurrencias; Hemorragias;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Prophylaxis; Medication adherence; Patient safety;
Keywords: ترومبوآمبولی وریدی; Anticoagulant drug; Guideline; Hip fracture; Haemorrhage; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; PE; pulmonary embolism; PROM; Patient Reported Outcome Measure; PESI; Pulmonary Embolism Severity Index; VTE; venous thromboembolism; VAS-score; visual analogue scale score; SF-36; short form health survey (36); DVT; deep venous thrombosis; LMWH; low-mole
Keywords: ترومبوآمبولی وریدی; Anticoagulants; Venous thromboembolism; Real world; Pulmonary embolism; Intermediate-high risk; Warfarin; Anticoagulantes; Tromboembolismo venoso; Mundo real; Embolia pulmonar; Risco intermédio a elevado; Varfarina;
Keywords: ترومبوآمبولی وریدی; Kidney disease; Nephrotic syndrome; Venous thromboembolism; Gender;
Keywords: ترومبوآمبولی وریدی; Trauma; Splenic injury; Platelets; Splenectomy; Thrombocytosis; Venous thromboembolism; Non-operative management; Embolization; Acetylsalicylic acid;
Keywords: ترومبوآمبولی وریدی; Anticoagulants; Venous thromboembolism; Real world; Pulmonary embolism; Intermediate-high risk; Warfarin; Anticoagulantes; Tromboembolismo venoso; Mundo real; Embolia pulmonar; Risco intermédio a elevado; Varfarina;
Keywords: ترومبوآمبولی وریدی; Acute leukemia; Cancer; Thrombosis; Venous thromboembolism; Recurrence;
Keywords: ترومبوآمبولی وریدی; Pediatric; Venous thromboembolism; Risk stratification; Cystic fibrosis;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Laparoscopic abdominal operation; Pulmonary embolism; VTE; Venous thromboembolism; DVT; Deep vein thrombosis; PE; Pulmonary embolism; NSQIP; National Surgical Quality Improvement Program; SSI; Superficial surgical site infection; A
Keywords: ترومبوآمبولی وریدی; Direct oral anticoagulants; Venous thromboembolism; Japanese; Meta-analysis;
Keywords: ترومبوآمبولی وریدی; Randomised controlled trial; Venous thromboembolism; Deep vein thrombosis; Graduated compression stockings; Low molecular weight heparin; Thromboprophylaxis;
Keywords: ترومبوآمبولی وریدی; Static graduated compression stockings; Pressure injury; Intensive care; Surgical patients; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Anaplastic lymphoma kinase (ALK); NSCLC; Thrombosis; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; ACCP; American College of Chest Physicians; BMI; body mass index; RAM; risk assessment model; VTE; venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Cancer; Diagnosis; Hypercoagulability; Occult primary neoplasm; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Thromboprophylaxis; Risk assessment; Deep vein thrombosis; Pulmonary embolism;
Keywords: ترومبوآمبولی وریدی; Prophylactic vena cava filter; Trauma; Venous thromboembolism; Pulmonary embolism; Cost analysis;
Keywords: ترومبوآمبولی وریدی; DVT; deep vein thrombosis; EMR; electronic medical record; LMWH; low molecular weight heparin; VTE; venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Pediatric; Trauma; Deep venous thrombosis; Pulmonary embolism; Prevention;
Keywords: ترومبوآمبولی وریدی; Ovarian cancer; Venous thromboembolism; Tissue factor; Microvesicles; Clear cell carcinoma;
Keywords: ترومبوآمبولی وریدی; Anticoagulants; Arthroplasty; Aspirin; Prevention; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Direct oral anticoagulants; Renal; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Anticoagulants; Warfarin; Hemorrhage; Venous thromboembolism; Atrial fibrillation;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Occult malignancy; Limited screening strategy; Extensive screening strategy; Meta-analysis;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Contraception; Anticoagulants; Haemorrhage; Therapeutics;
Keywords: ترومبوآمبولی وریدی; AIS; abbreviated injury score; ARDS; acute respiratory distress syndrome; CI; confidence interval; DNR; do-not-resuscitate; ED; emergency department; GCS; glasgow coma scale; GLMM; generalized linear mixed model; IQR; interquartile range; ISS; injury seve
Keywords: ترومبوآمبولی وریدی; Enoxaparin; Pancreatic resection; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Obesity; Bariatric surgery; Venous thromboembolism; Thromboprophylaxis; Survey;
Keywords: ترومبوآمبولی وریدی; Deep venous thrombosis; Prophylaxis; Pulmonary embolism; Urology; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; DVT; deep vein thrombosis; PE; pulmonary embolism; VTE; venous thromboembolism; PTS; post-thrombotic syndrome; CTPH; chronic thromboembolic pulmonary hypertension; IVCT; inferior vena cava thrombosis; BCS; Budd-Chiari Syndrome; CDT; catheter-directed thro
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Pharmacologic prophylaxis; Gynecologic surgery; Deep vein thrombosis; Pulmonary embolism;
Keywords: ترومبوآمبولی وریدی; Pediatric thrombosis; Long term outcomes; Poor outcomes; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; AF; atrial fibrillation; BWH; Brigham and Women's Hospital; DOACs; direct oral anticoagulants; HULP; Hospital Universitario La Paz; INR; international normalized ratio; IPAH; idiopathic pulmonary arterial hypertension; IQR; interquartilic range; mPAP; mea
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Medicare claims; Deep venous thrombosis; Pulmonary embolism;
Keywords: ترومبوآمبولی وریدی; Spinal cord injury; Thromboprophylaxis; Low-molecular weight heparin; Venous thromboembolism;
Keywords: ترومبوآمبولی وریدی; Cancer; Venous thromboembolism; Lysine analogue; Surgery; Blood transfusion;
Keywords: ترومبوآمبولی وریدی; Venous thromboembolism; Deep vein thrombosis; Pulmonary embolism; Bleeding event; Healthcare database;
Keywords: ترومبوآمبولی وریدی; Oral contraceptives; Venous thromboembolism; Endogenous thrombin potential; Protein C;
Keywords: ترومبوآمبولی وریدی; Deep vein thrombosis; Venous thromboembolism; Pulmonary embolism; Prophylaxis; Risk factors; Treatment; Perioperative clearance;
Keywords: ترومبوآمبولی وریدی; IVR; filter; venous thromboembolism; DVT; PE;
Keywords: ترومبوآمبولی وریدی; ACS NSQIP PUF; American College of Surgeons National Surgical Quality Improvement Program Participant Use File; CI; confidence interval; CPT; Current Procedural Terminology; ICD-9-CM; International Classification of Diseases Ninth Revision Clinical Modifi
Keywords: ترومبوآمبولی وریدی; PE; pulmonary embolism; TEG; thromboelastography; PS; phosphatidyl serine; VTE; venous thromboembolism; ROS; reactive oxygen; MP; microparticle; MA; maximum amplitude; AA; arachidonic acid; ADP; adenosine diphosphate; ETS; electron transport system; Apopt
Development, validation, and clinical pharmacokinetic application of ultra-performance liquid chromatography/tandem mass spectrometry method for simultaneously determining a novel recombinant hirudin derivative (Neorudin) and its active metabolite in huma
Keywords: ترومبوآمبولی وریدی; EH; EPR-hirudin, Neorudin; HV2; hirudin variant 2-Lys47; VTE; venous thromboembolism; Anticoagulant fusion protein; Hirudin variant 2-Lys47; Human serum; Pharmacokinetics; Recombinant neorudin; UPLC-MS/MS;